News from CROI 2022 – caveats using antiretrovirals as HIV prophylaxis
News from CROI 2022 – caveats using antiretrovirals as HIV prophylaxis
Pablo Barreiro 1, Vicente Soriano 2
1 Department of Infectious Diseases, Hospital Carlos III-La Paz University Hospital. Madrid, Spain; 2 UNIR Health Sciences School and Medical Center, Universidad Internacional de La Rioja, Madrid, Spain
*Correspondence: Pablo Barreiro, Email not available
Abstract
The annual conference on retroviruses and opportunistic infections was held in Denver, CO, last February. Most sessions were attended by virtual attenders, due to restrictions forced by the COVID-19 surge caused by the Omicron variant.
